U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849882) titled 'Dubousset Functional Test: an Investigation of Its Validity and Reliability in Individuals with Multiple Sclerosis' on Feb. 17.
Brief Summary: Multiple sclerosis (MS) is an autoimmune disease characterized by neuroinflammation and neurodegeneration in the central nervous system. The disease affects the white matter, cortex and deep gray matter of the central nervous system and is characterized by inflammatory-demyelinating lesions and neuronal/axonal degeneration. Demyelination associated with these lesions and the accompanying axonal degeneration are responsible for neurological disability in MS. There are many scales and mobility ...